Market closed

LivaNova/$LIVN

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About LivaNova

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.

Ticker

$LIVN

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

London, United Kingdom

Employees

2,900

Website

www.livanova.com

LivaNova Metrics

BasicAdvanced

$2.6B

110.47 $0.43

0.99 -

Price and volume

Market cap

$2.6B

Beta

0.99

52-week high

$64.48

52-week low

$43.15

Average daily volume

502K

Financial strength

Current ratio

3.37

Quick ratio

1.675

Long term debt to equity

49.496

Total debt to equity

51.176

Interest coverage (TTM)

2.79%

Management effectiveness

Return on assets (TTM)

3.77%

Return on equity (TTM)

1.87%

Valuation

Price to earnings (TTM)

110.468

Price to revenue (TTM)

2.067

Price to book

1.97

Price to tangible book (TTM)

9.2

Price to free cash flow (TTM)

23.626

Growth

Revenue change (TTM)

11.04%

Earnings per share change (TTM)

760.58%

3-year revenue growth (CAGR)

6.26%

3-year earnings per share growth (CAGR)

-62.89%

What the Analysts think about LivaNova

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for LivaNova stock.

LivaNova Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

LivaNova Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

LivaNova News

AllArticlesVideos

LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

Business Wire·1 month ago

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

Business Wire·2 months ago

LivaNova PLC (LIVN) Q3 2024 Earnings Call Transcript

Seeking Alpha·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LIVN

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for LivaNova stock?

LivaNova (LIVN) has a market cap of $2.6B as of January 15, 2025.

What is the P/E ratio for LivaNova stock?

The price to earnings (P/E) ratio for LivaNova (LIVN) stock is 110.47 as of January 15, 2025.

Does LivaNova stock pay dividends?

No, LivaNova (LIVN) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next LivaNova dividend payment date?

LivaNova (LIVN) stock does not pay dividends to its shareholders.

What is the beta indicator for LivaNova?

LivaNova (LIVN) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.